Tumor necrosis factor-α 238 G/A polymorphism and gastric cancer risk: A meta-analysis

Tumor Biology

Volumn 34, Issue 6, 2013, Pages 3859-3863

  Yu, Jian Yong ^a   Li, Li ^b   Ma, Heng ^a   Liu, Kai ^a   Cheng, Xurui ^a   Li, Yan Liang ^a   Song, Xi Lin ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b Wendeng Osteopathic Hospital   (China)

Author keywords

Gastric cancer; Meta analysis; Polymorphism; TNF 238 G A a

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA 238; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; ETHNICITY; GENETIC ASSOCIATION; HUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; STOMACH CANCER;

EID: 84891483186     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0972-z     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology. 2005;128:1567-78.
3. Polk DB, Peek Jr RM. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 2010;10:403-14.
4. Wroblewski LE, Peek Jr RM. Helicobacter pylori in gastric carcinogenesis: mechanisms. Gastroenterol Clin North Am. 2013;42:285-98.
5. Lamb A, Chen LF. Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer. J Cell Biochem. 2013;114:491-7.
6. Vendramini-Costa DB, Carvalho JE. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des. 2012;18:3831-52.
7. Chu WM. Tumor necrosis factor. Cancer Lett. 2013;328:222-5.
8. Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14:e218-228.
9. Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol. 2005;23:23-68.
10. Gorouhi F, Islami F, Bahrami H, Kamangar F. Tumour-necrosis factor-α polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer. 2008;98:1443-51.
11. Persson C, Canedo P, Machado JC, El-Omar EM, Forman D. Polymorphisms in inflammatory response genes and their association with gastric cancer: a huge systematic review and meta-analyses. Am J Epidemiol. 2011;173:259-70.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
13. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
15. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, et al. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001;166:41-6.
16. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer. 2003;104:617-23.
17. Lee SG, Kim B, Yook JH, Oh ST, Lee I, Song K. TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population. Cytokine. 2004;28:75-82.
18. Wu MS, Chen LT, Shun CT, Huang SP, Chiu HM, Wang HP, et al. Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int J Cancer. 2004;110:695-700.
19. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631-6.
20. Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine. 2005;29:141-52.
21. Kamangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, Shugart YY, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Canc Causes Contr. 2006;17:117-25.
22. Xing P, Xiao D, Zeng Q, Gao W. Relationship between cytokine gene polymorphisms on development and clinical characteristics of gastric adenocarcinoma. Chin J Gen Surg. 2006;15:659-63.
23. Garcia-Gonzalez MA, Lanas A, Quintero E, Nicolas D, Parra-Blanco A, Strunk M, et al. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a nationwide multicenter study in Spain. Am J Gastroenterol. 2007;102:1878-92.
24. Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, et al. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis. 2007;28:118-23.
25. Zeng QD, Lu LH, Xing PX, Lu B, Wang YS. Relationship between cytokine gene polymorphism and development of gastric adenocarcinoma. Zhonghua Yi Xue Za Zhi. 2007;87:1037-9.
26. Crusius JB, Canzian F, Capella G, Pena AS, Pera G, Sala N, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Ann Oncol. 2008;19:1894-902.
27. Yang JJ, Ko KP, Cho LY, Shin A, Gwack J, Chang SH, et al. The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study. BMC Cancer. 2009;9:238.
28. Bai JP, Guo Y, Chen R, Shen Y, Zhang P. Study on gastric cancer susceptibility genes in ethnic Hani and Yi populations with Helicobacter pylori infection in Yunnun Province. Chin Eur J Gastroenterol Hepatol. 2010;14:669-73.
29. Yi D, Wang Q, Wang F, Meng T, Ge L. Relationship between tagSNPs and haplotype of TNF-α gene and gastric cancer in Uygur and Han ethnic groups in Xinjiang. Carcinog Teratog Mutagen. 2012;24:261-5.
30. Shen C, Sun H, Sun D, Xu L, Zhang X, Liu A, et al. Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2011;126:763-70.
31. Zhang HL, Zhang YJ. A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer. Tumour Biol. 2013;34:1659-65.